Marwood Group

Don't miss our next webinar with Holland & Knight LLP: The Consumerization of Healthcare: GLP-1s, GenAI & Beyond. Our teams will break down the legal, regulatory, and commercial dynamics blurring the line between patient and consumer - from evolving FDA wellness guidance, to e-prescribing through DTC telehealth, to the latest healthcare applications of generative AI. Register now: mrwd.co/GLP1_HK26webinar

As part of our ongoing whitepaper series, Marwood and Sidley Austin LLP bring together legal, policy, and market perspectives on physician practice management. Our latest piece examines how shifting cost, reimbursement, and rate dynamics are redefining the #PPM model - and what it takes to build durable value going forward. Read more: mrwd.co/PPM_Sidley2026

After years of pricing pressure and market access challenges, the UK may be repositioning itself as a more viable launch market. The new UK x US pharmaceutical agreement introduces lower rebate burdens, higher NICE thresholds, and greater trade certainty - but questions remain around durability. Read our latest whitepaper, diving into what this means for investors, revenue visibility, and launch strategy: mrwd.co/USUkPharmaDeal2026

Marwood Group's Life Sciences & HealthTech team is hiring! Apply below or reach out to me if you're interested

We’re excited to be partnering with Private Capital Global for the 2026 MedTech Capital Connect Conference next month! Bringing together leading #MedTech investors & operators in Boston, this conference covers capital formation, scaling strategies, and value creation across the industry. And don’t miss a special fireside chat with our Head of Life Sciences & HealthTech Nayan Ghosh diving into key trends & dynamics shaping MedTech investing today. Learn more and register here: mrwd.co/PCGmedtech2026

We’re seeing CMS intensify its focus on fraud, waste, and abuse - moving beyond Minnesota to target new high-risk states while taking additional steps to curb DME-related activity. Join our next webinar this Friday March 27th as we break down the latest enforcement trends and what operators need to watch across high-risk states and #DME. Register here: https://lnkd.in/ev_KtEDd

We’re excited to be sponsoring Kayo Conference Series' Women’s Healthcare Private Equity Summit this summer in DC! Bringing together leading healthcare investors, operators, and advisors, this exclusive conference focuses on key trends, opportunities, and leadership perspectives shaping healthcare private equity And don't miss our Managing Director Jennifer Meyers speaking on the panel “Private Equity’s Impact on Healthcare” - diving into how PE partnerships can drive value creation, which performance metrics truly matter, and how leadership teams build culture and accountability as organizations scale. Register here: mrwd.co/Kayo2026

Healthcare AI is everywhere. Durable healthcare AI businesses are not. Three things are becoming clear in 2026: 1. Many AI/ML healthcare tools will remain outside FDA premarket review 2. FDA guidance is clarifying the boundary (including when authorization may not be required) 3. The most durable, category-defining companies are increasingly pairing AI with FDA authorization + product-specific coding + reimbursement A growing cohort of companies like Heartflow, Cleerly, Digital Diagnostics, Viz.ai, RapidAI, and Tempus AI have helped define an emerging path to market anchored by: — Verified safety/quality/validation through FDA authorization — Coding and reimbursement milestones that enable provider adoption — Platform strategies with scalable commercialization (not just one-off deployments) In our latest whitepaper, we explore why Software as a Medical Device #SaMD may represent the most durable go-to-market strategy for AI/ML healthcare innovation. Read more: mrwd.co/SaMDwhitepaper2026

Limited space remaining! Join us in New York this Thursday evening as our Head of Life Sciences & HealthTech Nayan Ghosh leads a panel discussion on emerging trends shaping #biomedical innovation at the Biomedical Innovation Showcase https://luma.com/oe4lq30n

Thrilled to have our Managing Director Joseph Mercer & Senior Advisor David Klein speak with Scott Becker on the latest episode of Becker Business Media podcast, diving into regulatory shifts, state budget dynamics, compliance trends, and key opportunities shaping #Healthcare investing. Listen now: mrwd.co/BeckersPodcast2026